« Mannitol (d-) » dans la base de données de produits chimiques Reptox de la CSST (organisme québécois responsable de la sécurité et de la santé au travail), consulté le 25 avril 2009
doi.org
dx.doi.org
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Edward Rockenstein et Christina Patrick, « A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD) », The Journal of Biological Chemistry, vol. 288, no 24, , p. 17579–17588 (ISSN1083-351X, PMID23637226, PMCID3682557, DOI10.1074/jbc.M112.434787, lire en ligne, consulté le )
foodproductdesign.com
(en) R Steagall & L O’Brien Nabors, « Polyols: Beyond Sweet Taste », sur www.foodproductdesign.com, (consulté le )
greenlineshop.it
(it) Schicchi, R., et al., « Caratterizzazione chimica della manna estratta nelle Madonie (Sicilia) da cultivar di Fraxinus angustifolia e di Fraxinus ornus (Oleaceae). », Quad. Bot. Amb. Appl, vol. 17, no 2, , p. 151-174 (lire en ligne)
issn.org
portal.issn.org
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Edward Rockenstein et Christina Patrick, « A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD) », The Journal of Biological Chemistry, vol. 288, no 24, , p. 17579–17588 (ISSN1083-351X, PMID23637226, PMCID3682557, DOI10.1074/jbc.M112.434787, lire en ligne, consulté le )
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Edward Rockenstein et Christina Patrick, « A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD) », The Journal of Biological Chemistry, vol. 288, no 24, , p. 17579–17588 (ISSN1083-351X, PMID23637226, PMCID3682557, DOI10.1074/jbc.M112.434787, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Edward Rockenstein et Christina Patrick, « A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD) », The Journal of Biological Chemistry, vol. 288, no 24, , p. 17579–17588 (ISSN1083-351X, PMID23637226, PMCID3682557, DOI10.1074/jbc.M112.434787, lire en ligne, consulté le )
